U.S. market Closed. Opens in 1 day 8 hours 45 minutes

XRTX | XORTX Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-02-28
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue141.96K75.27K17.88K20.44K19.90K19.32KN/AN/AN/A
Gross Profit-141.96K-75.27K-17.88K-20.44K-19.90K-19.32KN/AN/AN/A
Operating Expenses4.81M9.86M2.86M1.30M565.97K1.16M464.07K405.34K36.92K
Selling, General & Admin2.39M2.29M1.58M1.10M506.17K795.65K380.92K389.31K36.92K
Research & Development2.41M6.49M669.11K277.45K39.90K342.25K66.37KN/AN/A
Other Operating Expenses0N/AN/AN/AN/A-2.64MN/AN/AN/A
Operating Income-4.81M-10.69M-4.14M-1.30M-565.97K-1.16M-469.44K-405.34K-36.92K
Other Expenses / Income2.65M2.95M1.25M-202.36K-63.61K-2.71M-47.09K-25.52KN/A
Before Tax Income-2.15M-6.99M-1.30M-1.28M-629.58K-3.78M-474.20K-414.83K-36.92K
Income Tax ExpensesN/A04.39K13.51K37.21K22.30K10.09K8.62KN/A
Net Income-2.15M-6.99M-1.30M-1.28M-629.58K-3.78M-474.20K-414.83K-36.92K
Interest ExpensesN/AN/A4.39K13.51K37.21K22.30K15.46K8.62KN/A
Basic Shares Outstanding1.98M1.48M1.09M740.45K595.49K584.99K211.45K202.74K75.57K
Diluted Shares Outstanding1.98M1.48M1.09M740.45K595.49K584.99K211.45K202.74K75.57K
EBITDA-4.87M-9.41M-1.63M-1.25M-572.47K-1.07M-427.11K-389.31K-36.92K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-2.15M-6.99M-1.29M-1.26M-555.15K-3.73M-448.65K-397.58K-36.92K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-02-28
An error has occurred. This application may no longer respond until reloaded. Reload 🗙